National Cancer Institute
Bethesda, Maryland, United States
Purpose
to evaluate the non-inferiority of 1-dose of Cervarix (HPV2) in girls vs. 3-doses of Gardasil (HPV4) in women
Division
Global Health
Date
February 2020
Region Served
GLOBAL
Committed amount
$1,000,000
Grant topic
Vaccine Development
Duration (months)
54
Grantee location
Bethesda, Maryland, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.